Skip to main content

MoneyWorks4Me

Vivanza Biosciences - Quaterly Results

06 Feb 2024 Evaluate
The sales is pegged at Rs. 33.66 millions for the December 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 48.01 millions during the year-ago period.Profit after Tax for the quarter ended December 2023 saw a decline of -56.35% from Rs. 4.17 millions to Rs. 1.82  millions.Operating Profit reported a sharp decline to 2.85 millions from 5.29 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 33.66 48.01 -29.89 121.14 81.88 47.95 142.07 91.48 55.30
Other Income 0.18 0.10 80.00 0.84 2.62 -67.94 3.87 8.28 -53.26
PBIDT 2.85 5.29 -46.12 10.18 9.40 8.30 11.08 8.77 26.34
Interest 1.02 1.11 -8.11 3.21 3.13 2.56 4.18 4.06 2.96
PBDT 1.83 4.18 -56.22 6.97 6.27 11.16 6.90 4.71 46.50
Depreciation 0.01 0.01 0.00 0.03 0.03 0.00 0.03 0.07 -57.14
PBT 1.82 4.17 -56.35 6.94 6.24 11.22 6.87 4.64 48.06
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.18 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00
PAT 1.82 4.17 -56.35 6.94 6.24 11.22 5.69 4.64 22.63
Equity 40.00 40.00 0.00 40.00 40.00 0.00 40.00 40.00 0.00
PBIDTM(%) 8.47 11.02 -23.16 8.40 11.48 -26.80 7.80 9.59 -18.65
Peers
Company Name CMP
Redington 334.30
Adani Enterprises 2694.30
Amrapali Industries 32.05
Maxgrow India 164.55
Rashi Peripheral 638.05
View more..